| 1 |
|
Brief report Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome/
|
Cortes, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2 |
|
Brosilow-Ziff model for the CO-NO surface reaction on disordered two- and three-dimensional substrates (8 pages)/
|
Cortes, J
|
Published by the American Physical Society through the American Institute of Physics
|
1900
|
|
|
|
| 3 |
|
Brosilow-Ziff model for the CO-NO surface reaction on disordered two- and three-dimensional substrates (8 pages)/
|
Cortes, J
|
Published by the American Physical Society through the American Institute of Physics
|
2003
|
|
|
|
| 4 |
|
Effects of Age on Prognosis with Imatinib Mesylate Therapy for Patients with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia/
|
Cortes, J
|
Published for the American Cancer Society by J. Wiley [etc.]
|
2003
|
|
|
|
| 5 |
|
Kinetic phase transitions and reactive windows in reactions of monomers on two-dimensional lattices
|
Cortes, J
|
American Institute of Physics
|
1980
|
|
|
|
| 6 |
|
On the pair approximation method in a nonreactive catalytic system
|
Cortes, J
|
American Institute of Physics
|
1980
|
|
|
|
| 7 |
|
Response: dose escalation of imatinib may improve responses in patients with CML who fail standard-dose imatinib/
|
Cortes, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 8 |
|
Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha/
|
Cortes, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 9 |
|
Results of Imatinib Mesylate Therapy in Patients with Refractory or Recurrent Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Myeloproliferative Disorders/
|
Cortes, J
|
Published for the American Cancer Society by J. Wiley [etc.]
|
2003
|
|
|
|
